Long‐term outcomes in heart failure with preserved ejection fraction: Predictors of cardiac and non‐cardiac mortality
暂无分享,去创建一个
J. Daubert | L. Lund | E. Oger | E. Donal | G. Savarese | C. Linde | L. Benson | C. Hage | A. Venkateshvaran | M. Hourqueig | A. Shahim
[1] G. Sinagra,et al. [ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: what's new?] , 2022, Giornale italiano di cardiologia.
[2] J. Daubert,et al. Predictors of long‐term outcome in heart failure with preserved ejection fraction: a follow‐up from the KaRen study , 2021, ESC heart failure.
[3] P. Ponikowski,et al. Cause of Death in Patients With Acute Heart Failure: Insights From RELAX-AHF-2. , 2020, JACC. Heart failure.
[4] P. Austin,et al. A review of the use of time‐varying covariates in the Fine‐Gray subdistribution hazard competing risk regression model , 2019, Statistics in medicine.
[5] M. Emdin,et al. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction , 2019, Journal of the American Heart Association.
[6] Erwan Donal,et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). , 2019, European heart journal.
[7] L. Lund,et al. Incidence of, Associations With and Prognostic Impact of Worsening Renal Function in Heart Failure With Different Ejection Fraction Categories. , 2019, The American journal of cardiology.
[8] J. McMurray,et al. Microvascular Disease in Patients With Diabetes With Heart Failure and Reduced Ejection Versus Preserved Ejection Fraction , 2019, Diabetes Care.
[9] L. Lund,et al. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction , 2019, Clinical Research in Cardiology.
[10] L. Lund,et al. Prevalence of, associations with, and prognostic role of anemia in heart failure across the ejection fraction spectrum. , 2019, International journal of cardiology.
[11] C. Cuspidi,et al. Obesity and heart failure with preserved ejection fraction: a paradox or something else? , 2019, Heart Failure Reviews.
[12] A. Gavazzi,et al. Prevalence and prognostic impact of non‐cardiac co‐morbidities in heart failure outpatients with preserved and reduced ejection fraction: a community‐based study , 2018, European journal of heart failure.
[13] L. Lund,et al. Associations With and Prognostic and Discriminatory Role of N-Terminal Pro-B-Type Natriuretic Peptide in Heart Failure With Preserved Versus Mid-range Versus Reduced Ejection Fraction. , 2018, Journal of cardiac failure.
[14] Akshay S. Desai,et al. Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction , 2018, European heart journal.
[15] Nicola Orsini,et al. Utilizing NT-proBNP for Eligibility and Enrichment in Trials in HFpEF, HFmrEF, and HFrEF. , 2018, JACC. Heart failure.
[16] Roland A Matsouaka,et al. Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes. , 2017, Journal of the American College of Cardiology.
[17] Sanjiv J. Shah,et al. Mode of Death in Heart Failure With Preserved Ejection Fraction. , 2017, Journal of the American College of Cardiology.
[18] G. Lip,et al. Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials , 2016, European heart journal.
[19] Erwan Donal,et al. Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study. , 2015, European heart journal cardiovascular Imaging.
[20] L. Lund,et al. New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study , 2015, European journal of heart failure.
[21] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[22] J. Daubert,et al. Association between cardiovascular vs. non‐cardiovascular co‐morbidities and outcomes in heart failure with preserved ejection fraction , 2014, European journal of heart failure.
[23] V. Melenovský,et al. Implications of coronary artery disease in heart failure with preserved ejection fraction. , 2014, Journal of the American College of Cardiology.
[24] J. Daubert,et al. Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study. , 2014, Archives of cardiovascular diseases.
[25] J. Daubert,et al. Rationale and design of the Karolinska‐Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction , 2009, European journal of heart failure.